Breaking News Bar
posted: 11/2/2013 5:00 AM

Restore funding for cancer screenings

hello
Success - Article sent! close
 

As we take some time this season to raise awareness about treating and preventing breast cancer, it's important to remember that many women do not have access to mammography. In fact, only 26 percent of uninsured women over 40 have had a screening in the past year.

We can help change those statistics by asking Congress to properly fund a breast and cervical screening program run by the Centers for Disease Control and Prevention. Over the past 20 years, this program has provided more than 10 million screenings to more than 4 million women. Right now, lack of funding currently limits access to screenings to one in five eligible women and, on top of that, the recent sequester is threatening access to an additional 32,000 screenings for women nationwide -- including 1,100 in Illinois.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

As a husband, father, uncle and grandfather, I urge Congress to restore funding for cancer prevention and make access to lifesaving screenings and treatments for women a priority.

Stephen Egan

Rolling Meadows

Illinois volunteer

American Cancer Society Cancer Action Network

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.